These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8763397)

  • 1. ATP-sensitive potassium channels, transmural ischemia and the ECG implications for the non-insulin dependent diabetic patient?
    Wilde AA
    Cardiovasc Res; 1996 May; 31(5):688-90. PubMed ID: 8763397
    [No Abstract]   [Full Text] [Related]  

  • 2. [ATP-sensitive potassium channels and substances affecting them].
    Pospísilová Y
    Vnitr Lek; 1998 Jul; 44(7):435-8. PubMed ID: 9748883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification, function mechanisms and regulation of potassium channels sensitive to ATP which are targets of sulfonylureas used in the treatment of type II diabetes mellitus].
    Fosset M; De Weille J; Schmid-Antomarchi H; Bernardi H; Lazdunski M
    Journ Annu Diabetol Hotel Dieu; 1989; ():7-11. PubMed ID: 2503655
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
    Hassouna A; Loubani M; Matata BM; Fowler A; Standen NB; Galiñanes M
    Cardiovasc Res; 2006 Feb; 69(2):450-8. PubMed ID: 16330008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
    Iskit AB; Erkent U; Ertunc M; Guc MO; Ilhan M; Onur R
    Vascul Pharmacol; 2007 Feb; 46(2):129-36. PubMed ID: 17064967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study.
    Gori T; Sicuro S; Dragoni S; Donati G; Forconi S; Parker JD
    Circulation; 2005 Feb; 111(6):742-6. PubMed ID: 15699265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylureas and mortality in diabetic patients after myocardial infarction.
    Brady PA; Al-Suwaidi J; Kopecky SL; Terzic A
    Circulation; 1998 Feb; 97(7):709-10. PubMed ID: 9495313
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular effects of sulphonylurea derivatives.
    Smits P
    Diabetologia; 1997 Jul; 40 Suppl 2():S160-1. PubMed ID: 9248730
    [No Abstract]   [Full Text] [Related]  

  • 9. Potassium channel blockade and acute myocardial infarction: implications for management of the non-insulin requiring diabetic patient.
    Hofmann D; Opie LH
    Eur Heart J; 1993 Dec; 14(12):1585-9. PubMed ID: 8131754
    [No Abstract]   [Full Text] [Related]  

  • 10. Ischemia in type 2 diabetes: tissue selectivity of sulfonylureas and clinical implications.
    Wascher TC; Boes U
    Metabolism; 2003 Aug; 52(8 Suppl 1):3-5. PubMed ID: 12939732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels].
    Larsson O; Kindmark H; Bränström R; Berggren PO
    Lakartidningen; 1997 Nov; 94(48):4473-7. PubMed ID: 9424548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An explanation for the reported observation that ATP dependent potassium channel openers mimic preconditioning.
    Downey JM
    Cardiovasc Res; 1993 Sep; 27(9):1565. PubMed ID: 8287432
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation.
    Brennan JP; Southworth R; Medina RA; Davidson SM; Duchen MR; Shattock MJ
    Cardiovasc Res; 2006 Nov; 72(2):313-21. PubMed ID: 16950237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-sensitive K+ channels.
    Lazdunski M; Allard B; Bernardi H; De Weille J; Fosset M; Heurteaux C; Honoré E
    Ren Physiol Biochem; 1994; 17(3-4):118-20. PubMed ID: 7518937
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
    Park EJ; Bae JH; Kim SY; Lim JG; Baek WK; Kwon TK; Suh SI; Park JW; Lee IK; Ashcroft FM; Song DK
    Biochem Pharmacol; 2004 Mar; 67(6):1089-96. PubMed ID: 15006545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased cardiovascular risk in patients with type 2 diabetes treated with sulfonylurea?].
    Asvold BO; Jonsbu M; Grill V
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2560-4. PubMed ID: 11070997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea derivatives in cardiovascular research and in cardiovascular patients.
    Schotborgh CE; Wilde AA
    Cardiovasc Res; 1997 Apr; 34(1):73-80. PubMed ID: 9217875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease.
    Tai KK; Truong DD
    J Neurosci Res; 2002 Aug; 69(4):559-66. PubMed ID: 12210849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium.
    Pomerantz BJ; Robinson TN; Morrell TD; Heimbach JK; Banerjee A; Harken AH
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):387-92. PubMed ID: 10917958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-regulated potassium channel blocker, glibenclamide, uncouples mitochondria.
    Szewczyk A; Czyz A; Nałecz MJ
    Pol J Pharmacol; 1997; 49(1):49-52. PubMed ID: 9431552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.